Investment case
HealthEquity, Inc.
HQY · 3 developments mapped · last assessed 2026-09-04
Market Ontology has mapped 3 macro, policy, and market developments to HealthEquity, Inc. since 2026-09-04. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for HQY yet, so no modelled value is shown. The HQY valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run HQY on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Open question
Phreesia falls 6.3% after Q2 net income misses expectations
Second-order effect: Potential re-evaluation of growth-oriented healthcare technology companies, especially those with patient engagement or financial transaction components, if Phreesia's profitability issues are perceived as systemic.
· Moves sector profitability outlook, investor risk appetite for growth stocks
What changed, by assumption
- 2026-09-04Phreesia falls 6.3% after Q2 net income misses expectations
- 2026-09-04Phreesia declines 6.3% on Q2 net income miss despite 10% revenue growth
- 2026-09-04Phreesia Falls 6.3% on Q2 Net Income Shortfall Despite 10% Revenue Growth to $129.5M
Assumption changes
Full ledger →| Date | Assumption | Direction | Why | Conf. |
|---|---|---|---|---|
| 2026-08-27 | Share count | Bearish | Repurchase reduces shares outstanding. | 0.70 |
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-04 | Phreesia falls 6.3% after Q2 net income misses expectations | watch | 1-3m | 0.30 |
| 2026-09-04 | Phreesia Falls 6.3% on Q2 Net Income Shortfall Despite 10% Revenue Growth to $129.5M | watch | 1-3m | 0.20 |
| 2026-09-04 | Phreesia declines 6.3% on Q2 net income miss despite 10% revenue growth | watch | 1-3m | 0.30 |